Page last updated: 2024-08-24

gemcitabine and conophylline

gemcitabine has been researched along with conophylline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Araki, K; Gantumur, D; Hagiwara, K; Handa, T; Harimoto, N; Igarashi, T; Ishii, N; Kubo, N; Kuwano, H; Masamune, A; Shirabe, K; Tsukagoshi, M; Umezawa, K; Watanabe, A; Yamanaka, T; Yokobori, T	1

Other Studies

1 other study(ies) available for gemcitabine and conophylline

Article	Year
Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts. Cancer science, 2019, Volume: 110, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer-Associated Fibroblasts; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Deoxycytidine; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Pancreatic Neoplasms; Pancreatic Stellate Cells; Tumor Burden; Vinca Alkaloids; Xenograft Model Antitumor Assays	2019

Article

Year

Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.

Cancer science, 2019, Volume: 110, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer-Associated Fibroblasts; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Deoxycytidine; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice, Inbred NOD; Mice, SCID; Pancreatic Neoplasms; Pancreatic Stellate Cells; Tumor Burden; Vinca Alkaloids; Xenograft Model Antitumor Assays

2019